glp-1 from china Innovent's weight-loss drug highlights challenge for Novo, Lilly GLP-1 GOSSIP - xoxo ,

The reported outcome of this campaign was a candidate that retained agonist activity at amylin/calcitonin-family receptors while displaying a markedly extended pharmacokinetic profile in the authors' preclinical models, and reduced food intake in rodent models following administration

doi:10.1186/s12916-023-02824-8 Huang T, Redline S

Whats clear is that, as the use of GLP-1 drugs for weight management increases, the market for targeted foods is likely to grow with it, creating myriad opportunities for manufacturers quick enough to make the move.

But the other drugs bring their own side effects

Comprehensive anti-aging stacks combining multiple bioregulators, GH peptides, and NAD+ support run $200 to $500 monthly research-grade or $600 to $1,500 clinical